Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study

RATIONALE & OBJECTIVE: Studies using a single measurement of fibroblast growth factor 23 (FGF-23) suggest that elevated FGF-23 levels are associated with increased risk for requirement for kidney replacement therapy (KRT) in patients with chronic kidney disease. However, the data do not account...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Kidney Dis
Autors principals: Mehta, Rupal, Cai, Xuan, Lee, Jungwha, Xie, Dawei, Wang, Xue, Scialla, Julia, Anderson, Amanda H., Taliercio, Jon, Dobre, Mirela, Chen, Jing, Fischer, Michael, Steigerwalt, Susan, Leonard, Mary, Lash, James, Hsu, Chi-yuan, de Boer, Ian H., Feldman, Harold I., Wolf, Myles, Isakova, Tamara
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7247939/
https://ncbi.nlm.nih.gov/pubmed/31864822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ajkd.2019.09.009
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars